SS Innovations International, Inc.
SSII Healthcare Medical Devices
SS Innovations International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $42.5 million, up 105.7% from fiscal 2024. In the quarter to June 2026, revenue grew 39.4%, EPS fell 669.2%, free cash flow fell 16.6% and total debt rose 109.7%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow SSII
SS Innovations International, Inc. (SSII) EV/Sales
As of 16 October 2026, SS Innovations International, Inc. (SSII) trades at a EV/Sales of 9.6×. Over the past ten years it has ranged from 5.1× (September 2024) to 107× (December 2024); the current reading is higher than 2% of that period. That is above the Medical Devices industry median of 2.2× and above the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 25.5× | (61.05%) |
| FY2024 | 65.4× | 4.56% |
| FY2023 | 62.5× | 0.00% |
| FY2022 | 62.5× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 15.7× | (21.35%) |
| Mar 2026 | 20.0× | (21.58%) |
| Dec 2025 | 25.5× | (26.94%) |
| Sep 2025 | 34.8× | (14.81%) |
| 10 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| TCMD Tactile Systems Technology, Inc. compare | 1.3× |
| CERS Cerus Corporation compare | 1.8× |
| KIDS OrthoPediatrics Corp. compare | 2.3× |
| BWAY Brainsway Ltd. Sponsored ADR compare | 2.6× |
| DCTH Delcath Systems, Inc. compare | 4.3× |
| SGHT Sight Sciences, Inc. compare | 4.9× |
| MASS 908 Devices Inc. compare | 5.6× |
| PACB Pacific Biosciences of California, Inc. compare | 5.9× |
| SSII SS Innovations International, Inc. | 9.6× |
| Medical Devices industry median | 2.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)